Diana Levine lost her hand to gangrene when she was injected with Phenergan, an anti-nausea drug made by Wyeth Pharmaceuticals. She won a jury verdict in Vermont, under the notion that Wyeth had inadequately labeled the drug.
If a drug meets the labeling requirements of the FDA, does that give rise to federal preemption of state law regarding inadequate labeling?
For more information on Sheller, P.C., visit www.sheller.com.
Link to this comment:
All Comments (0)